FDA Inspection 897817 — Resilience US, Inc.

Resilience US, Inc. — FEI 1000305672

The FDA completed an inspection of Resilience US, Inc. on September 25, 2014 in Allston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 25, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allston, MA (United States)

Citations

IDCFRDescription
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration